Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Hepatobiliary Cancers

Overview

About this study

The purpose of this study is to assess standardized benchmarks of intervention feasibility and acceptability for remotely delivered, group ACT-HBC, as tested with a single-arm pilot study. Determine if there are changes in psychological variables from baseline to completion of the ACT-HBC intervention. To explore the preliminary impact of rural status on feasibility and acceptability of the intervention in addition to outcomes of distress and theory-based statistical mediators/psychological mechanisms of ACT-HBC.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

HBC diagnosis
Age >18 years
Able to provide written informed consent
Verbally endorse cancer distress
Access to the Internet
Read and write in English
Reside in the states of Iowa, Minnesota, or Wisconsin

Exclusion Criteria:

Other psychological therapy that started <2 months prior to prospective enrollment
Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion.
HBC remission

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/15/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Carrie Bronars, Ph.D., L.P.	Open for enrollment	Contact information: Carrie Bronars Ph.D., L.P. (507) 284-2933 Bronars.Carrie@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Carrie Bronars, Ph.D., L.P.

Open for enrollment

Contact information:

Carrie Bronars Ph.D., L.P.

(507) 284-2933

Bronars.Carrie@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials